US funding for clinical research in South Africa is incrementally being cancelled. This is happening through at least two processes – the first is by banning certain kinds of foreign grants called sub-awards (which is affecting everyone globally). The second is by failing to issue routine renewals of grants for clinical studies in South Africa. Spotlight and GroundUp break down the current situation.
We’re watching the largest HIV treatment programme in the world unravelling in real time. We don’t need perfection, but we do need a combination of urgency, action, and strategy to save it, argues Professor Francois Venter.
In late-January, the US suspended billions of dollars worth of international aid, including for HIV-related programmes in South Africa. The South African government could have responded by triggering an emergency funding mechanism but has failed to do so yet. In the meantime, activists, health researchers and even technical advisors to government are growing increasingly frustrated with the government’s lack of transparency on this issue.
Top local researchers estimate that the cancellation of funding from the US President’s Emergency Plan for AIDS Relief could lead to a significant increase in HIV infections and deaths in South Africa. Jesse Copelyn reports.
There is no shortage of myths about the cancellation of US foreign assistance. This includes the widely held misconception that PEPFAR is exempt from US aid cuts and the belief that grant terminations are just taking place in South Africa. Many of these falsehoods have been reinforced by US and South African officials. Spotlight and GroundUp dissect some of the most popular misconceptions.
After the US slashed global aid, the South African government stated that only 17% of its HIV spending relied on US funding. But some experts argue that US health initiatives had more bang for buck than the government’s programmes. Jesse Copelyn looks past the 17% figure, and considers how the health system is being affected by the loss of US money.
South Africa faces its worst health crisis in 20 years. Worse than COVID, and one that will overshadow diabetes as a major killer, while pouring petrol on a dwindling TB fire. But it is preventable, argues Professor Francois Venter if our government steps up urgently.
South Africa’s public health system is in turmoil after the widespread cancellation of USAID funding agreements. Among others, a USAID-funded project that helped to keep orphaned children on their HIV medication was forced to close. HIV testing services are also severely impacted in some areas.
Despite a waiver on life-saving humanitarian aid, USAID funding for crucial medical services remains frozen. Services remain closed as organisations await approval of revised budgets limited to what is allowed under the waiver. A separate US agency – the Centers for Disease Control and Prevention – restored funding to its beneficiary organisations, allowing them to reopen thanks to a US court judgment.
A US-funded health facility in Pretoria shut its doors for over two weeks after an executive order by President Trump paused funding. A beneficiary of the centre, who is HIV-positive, said that he hadn’t taken his ARVs in roughly two weeks due to the closure. Many were in the same predicament. The health centre reopened on 13 February after funding resumed.
Stopping antiretroviral treatment when you are living with HIV can result in increased HIV transmission, illness, hospitalisation, and eventually death. To combat such disengagement with HIV treatment, Professor Graeme Meintjes and colleagues argue we need smarter differentiated care and better education of healthcare workers, people living with HIV, and communities.
Nthusang Lefafa looks at the latest Ritshidze report for key populations and speaks to some public healthcare experts about possible solutions to challenges facing those marginalised groups who carry a high burden of the HIV pandemic.
